Newsround

Newsround is a platform that provides the latest news and updates from around the world.

100+ Daily Updates
50+ Countries Covered

News Categories

Latest News

Speech by Governor Waller on the economic outlook - Federal Reserve Board (.gov)
business 2026/02/23 13:02:08

Speech by Governor Waller on the economic outlook - Federal Reserve Board (.gov)

Thank you, Constance, and thank you for the opportunity to speak to you today. 1 Let me commend NABE for focusing this year’s conference on economic disru

Federalreserve.gov
Read Full Story
Robotaxis are coming to London. The city’s famed black cab drivers are skeptical - AP News
business 2026/02/23 12:24:00

Robotaxis are coming to London. The city’s famed black cab drivers are skeptical - AP News

London is becoming a major test bed for robotaxis as companies prepare for government trials in the spring. Wayve has been running a self-driving Ford Mustang Mach-E on busy city streets. On a recent ride, it handles traffic, cyclists, and construction with a…

Associated Press
Read Full Story
What is Blue Owl, and why are people suddenly worried about private credit? - CNN
business 2026/02/23 12:00:33

What is Blue Owl, and why are people suddenly worried about private credit? - CNN

What is Blue Owl, and why are people suddenly worried about private credit?

CNN
Read Full Story
Finland's IQM to become one of Europe's first listed quantum companies at $1.8 billion valuation - CNBC
business 2026/02/23 12:00:10

Finland's IQM to become one of Europe's first listed quantum companies at $1.8 billion valuation - CNBC

The transaction will see the company hit a $1.8 billion valuation.

CNBC
Read Full Story
Merck to create separate cancer business as Keytruda patent loss looms - CNBC
business 2026/02/23 11:58:45

Merck to create separate cancer business as Keytruda patent loss looms - CNBC

Merck said on Monday it would split its business into two, creating ⁠a division for its cancer franchise while grouping its ​non-oncology treatments separately.

CNBC
Read Full Story
Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - CNBC
business 2026/02/23 11:40:07

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - CNBC

Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in ​its largest deal since 2020, the ​biopharma company said on ​Monday.

CNBC
Read Full Story